| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.24M | - | |
| Other | 67.7K | $2.38M | - | |
| CFO | 40.3K | $1.42M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $626.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Jones Cecilia48 | Chief Financial Officer | Sale+OE | 2,275 | $35.54 | $80,853.50 | -4.6% | -1.5% | -14.0% | |
| Feb 5, 2025 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sale+OE | 2,272 | $34.39 | $78,134.08 | -29.5% | -17.6% | -22.7% | |
| Jan 6, 2025 | Milanova Tsveta46 | Chief Commercial Officer | Sale+OE | 2,804 | $32.18 | $90,232.72 | -12.9% | -22.8% | -18.1% | |
| Dec 11, 2024 | Scadden David75 | Director | Sale+OE | 200 | $46.28 | $9,256.00 | -1.3% | -25.9% | -36.7% | |
| Nov 8, 2024 | Washburn Theodore James Jr.64 | Principal Accounting Officer | Sell | 772 | $56.09 | $43,301.48 | -48.7% | -41.7% | -31.1% | |
| Nov 8, 2024 | Ballal Rahul D.70 | Director | Sale+OE | 20,000 | $55.86 | $1,117,146.69 | -28.7% | -41.7% | -31.1% | |
| Nov 7, 2024 | Burns James William49 | Chief Legal Officer | Sell | 21,752 | $52.21 | $1,135,774.96 | -35.4% | -37.6% | -26.2% | |
| Sep 26, 2024 | Jones Cecilia48 | Chief Financial Officer | Sale+OE | 2,542 | $49.03 | $124,634.26 | -11.2% | -28.5% | -19.0% | |
| Aug 8, 2024 | Goff Brian50 | Chief Executive Officer | Sale+OE | 11,091 | $42.75 | $474,140.25 | -12.3% | +17.8% | -18.3% | |
| Jul 1, 2024 | Gheuens Sarah49 | Chief Medical Officer | Sale+OE | 3,705 | $43.85 | $162,464.25 | -7.8% | +2.4% | -20.8% |